{"schema_version": 1, "id": "portland-vancouver-beaverton-or-wa-msa/life-sciences/2026-10", "product": "Labor Market Pulse", "metro": {"geography_id": 347, "label": "Portland-Vancouver-Beaverton, OR-WA MSA", "slug": "portland-vancouver-beaverton-or-wa-msa"}, "focus_area": {"key": "life_sciences", "slug": "life-sciences", "label": "Life Sciences"}, "period": "2026-10", "public_after": "2026-10-01", "frozen_at": "2026-11-03T04:38:48.496036+00:00", "headline": "Portland life sciences pay climbs as broader metro jobs shrink.", "headline_summary": "Regulatory Affairs Specialist pay rose to a $114,400 metro median and Biostatistician pay hit $170,439, even as the Portland-Vancouver-Hillsboro metro posted the nation's second-largest annual job loss.", "key_indicators": [{"label": "Metro nonfarm job loss", "value": "32,600", "context": "March 2025\u2013March 2026, 2nd worst among U.S. metros"}, {"label": "Portland metro unemployment", "value": "4.8%", "context": "vs 4.2% U.S. rate, August 2026"}, {"label": "Biostatistician pay growth", "value": "$170,439", "context": "Metro median, significant increase vs national $131,958"}, {"label": "CRA pay divergence", "value": "$76,986 vs $90,065", "context": "Metro down moderately while national rises significantly"}], "takeaways": [{"headline": "Regulatory and data roles are pulling away from the pack.", "body": "Regulatory Affairs Specialist pay rose significantly to a $114,400 metro median while Clinical Data Manager and Biostatistician roles climbed to $150,104 and $170,439 respectively \u2014 all against a metro that lost 32,600 jobs over the past year. Scarcity in credentialed, compliance-adjacent talent appears to be insulating these roles from the broader downturn."}, {"headline": "Clinical Research Associate pay is diverging from the national trend.", "body": "Metro CRA pay fell to a $76,986 median while national CRA pay rose to $90,065, a gap that may reflect Portland's smaller clinical trial infrastructure relative to larger biopharma hubs. Organizations with CRO relationships should evaluate whether this cost advantage justifies reallocating clinical operations work locally at these more favorable rates."}, {"headline": "Lab Technician pay growth suggests an entry-level squeeze alongside broader wage pressure.", "body": "Metro Lab Technician pay rose to $60,505, moderately ahead of a national median that held flat at $47,840. Rising entry-level lab pay alongside Oregon's semiconductor-biotech talent overlap may signal technicians are being drawn toward adjacent industries, tightening the pipeline employers rely on for bench-level hiring."}, {"headline": "Validation Engineer pay softening could reflect manufacturing caution.", "body": "Metro Validation Engineer pay declined moderately to $111,269, tracking a national figure that held stable. Softening in this role, set against sustained national hiring strength in bioprocess and automation engineering, may indicate Portland manufacturers are pacing capital projects more conservatively than peer markets."}], "local_conditions": "Portland-Vancouver-Hillsboro's 32,600 nonfarm job losses between March 2025 and March 2026 mark the second-steepest metro decline in the country, yet life sciences remains an outlier: Oregon's biotech concentration runs nearly 2.5 times the national average, and OHSU's $650 million hospital expansion is projected to support 3,000 new positions even as broader metro employment contracts. Regional labor supply is further constrained by cross-industry competition, as semiconductor employers draw from the same technical and engineering talent pool that life sciences manufacturers and R&D teams need to fill bioprocess, automation, and quality roles.", "implications": "Broad metro job losses mask a bifurcated reality for life sciences leaders: regulatory affairs, clinical data management, and biostatistics roles are seeing significant local pay increases even as overall headcount in the metro contracts, signaling that credentialed scientific and regulatory talent is being bid up independently of general labor market softness. Build-vs-outsource calculus should account for this divergence \u2014 CRA advertised pay has fallen locally while rising nationally, suggesting Portland employers may have more room to build internal clinical operations capacity than peer metros where CRA costs are accelerating faster. Consider reviewing whether current CRO/CDMO contract terms reflect this metro's comparatively favorable CRA cost position before renewing at national benchmark rates.", "looking_ahead": [{"category": "Early indicator", "body": "PacificSource's fourth round of layoffs since September 2025, cutting 134 workers by year-end, may release healthcare-adjacent talent with regulatory and compliance experience into the regional pool. Watch whether this creates near-term relief for life sciences employers competing for pharmacovigilance and quality talent."}, {"category": "Worth watching", "body": "Oregon's state goal to double direct and indirect life sciences employment over the next decade sits uneasily against a metro that has shed jobs faster than nearly every other U.S. metro area. Expect continued divergence between state-level growth ambitions and near-term hiring caution at the employer level."}, {"category": "Potential inflection point", "body": "National quit rates remain low at 1.9%, meaning experienced regulatory and clinical staff are largely staying put \u2014 watch for counteroffer activity to intensify locally as Q4 searches for regulatory affairs and medical affairs talent run longer than usual."}, {"category": "Emerging pressure point", "body": "OHSU's hospital expansion ramping toward 3,000 new positions will compete directly with biotech and pharma employers for clinical, quality, and regulatory-adjacent talent in the same metro labor pool. Monitor whether OHSU's hiring pace forces compensation adjustments for comparable roles at biotech and device employers."}], "roles": [{"role": "Research Scientist", "data_scope": "metro", "metro_p25": 147797.0, "metro_p50": 148237.0, "metro_p75": 148237.75, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 130339.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Clinical Research Associate", "data_scope": "metro", "metro_p25": 63074.5, "metro_p50": 76986.0, "metro_p75": 96967.0, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 90065.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Lab Technician", "data_scope": "metro", "metro_p25": 45169.0, "metro_p50": 60505.2, "metro_p75": 66499.5, "metro_trend_direction": "up", "metro_trend_magnitude": "moderate", "national_p50": 47840.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Regulatory Affairs Specialist", "data_scope": "state_rollup", "metro_p25": 89038.25, "metro_p50": 114400.0, "metro_p75": 118621.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 103779.6, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Clinical Data Manager", "data_scope": "state_rollup", "metro_p25": 112499.0, "metro_p50": 150104.0, "metro_p75": 220000.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 123653.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Biostatistician", "data_scope": "state_rollup", "metro_p25": 116478.0, "metro_p50": 170439.2, "metro_p75": 170747.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 131958.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Validation Engineer", "data_scope": "metro", "metro_p25": 93496.0, "metro_p50": 111269.4, "metro_p75": 115014.0, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 106478.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}], "industry_snapshot": [], "citations": [{"source_name": "Bureau of Labor Statistics / Traders Union", "source_url": null, "statement": "Metro lost 32,600 nonfarm jobs March 2025\u2013March 2026, 2nd-largest U.S. decline"}, {"source_name": "Greater Portland Real Estate Analysis", "source_url": null, "statement": "OHSU opened $650 million hospital expansion expected to support 3,000 jobs"}, {"source_name": "Oregon Life Sciences / Thermo Fisher Scientific", "source_url": null, "statement": "Oregon biotech concentration nearly 2.5x national average"}, {"source_name": "Oregon WARN Act filings", "source_url": null, "statement": "PacificSource layoff of 134 workers by Dec. 31, 2026, fourth round since Sept. 2025"}, {"source_name": "USAFacts / Bureau of Labor Statistics", "source_url": null, "statement": "Portland metro unemployment at 4.8% in August 2026"}, {"source_name": "Bureau of Labor Statistics", "source_url": null, "statement": "National quit rate at 1.9%, indicating low voluntary turnover among experienced staff"}], "methodology": "Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay.", "edition_label": "November 2026", "files": {"html": "portland-vancouver-beaverton-or-wa-msa/life-sciences/2026-10.html", "pdf": "portland-vancouver-beaverton-or-wa-msa/life-sciences/2026-10.pdf"}, "published_at": "2026-11-03T08:28:31.015674+00:00", "report_html_url": "https://reports.wagescape.com/archive/v1/editions/portland-vancouver-beaverton-or-wa-msa/life-sciences/2026-10.html", "report_pdf_url": "https://reports.wagescape.com/archive/v1/editions/portland-vancouver-beaverton-or-wa-msa/life-sciences/2026-10.pdf"}